Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00469365 · ClinicalTrials.gov registry record · Phase 3
Pharmacy Interventions to Improve Chronic Disease Medication Refill
A Phase 3 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 3
- Development phase
- 3,048
- Enrollment target
NCT00469365: Completed Phase 3 study, sponsored by Medical University of South Carolina.
NCT00469365 is a Phase 3 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 3,048 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (295% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00469365, a Phase 3 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 3,048 participants
- Enrollment target
Study Summary
Compare the effectiveness of 3 strategies by pharmacists to decrease the time to refill of prescriptions for common chronic diseases (diabetes, hypertension, hyperlipidemia, heart failure, depression, psychoses).
Interventions
- BEHAVIORAL Usual care
- BEHAVIORAL pharmacist contact with the patient via telephone
- BEHAVIORAL Pharmacist contact with the patient's physician via fax
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,048 participants |
| Start Date | 2006-01 |
| Est. Completion | 2006-08 |
| Phase | Phase 3 |
What the finished NCT00469365 record still lists
NCT00469365 is an interventional study that assigns participants to a tested intervention. Its 3,048 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (295% higher).
The record links to 0 conditions, and to 3 interventions - of which Usual care is the first listed.
NCT00469365 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00469365 about?
NCT00469365 is a clinical study titled "Pharmacy Interventions to Improve Chronic Disease Medication Refill". Compare the effectiveness of 3 strategies by pharmacists to decrease the time to refill of prescriptions for common chronic diseases (diabetes, hypertension, hyperlipidemia, heart failure, depression, psychoses).
What is the current status of trial NCT00469365?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 3,048 participants. The study started on 2006-01. Estimated completion is 2006-08.
What interventions are being tested in trial NCT00469365?
The interventions under investigation include: Usual care (BEHAVIORAL), pharmacist contact with the patient via telephone (BEHAVIORAL), Pharmacist contact with the patient's physician via fax (BEHAVIORAL).
Who is sponsoring clinical trial NCT00469365?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00469365's enrollment target sits among peer trials
3,048 77th of 2000 higher than 1,924 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07116967 · 3,040 participants · Phase 3
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
- NCT06667700 · 3,082 participants · Phase 3
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- NCT05534243 · 3,090 participants · NA
The ED-AWARENESS-2 Trial
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia